Table 1 Demographic and baseline characteristics
|  | GUT-1 (n = 5) |
|---|---|
Male (n) | 4 |
Female (n) | 1 |
Mean age (years) | 38.2 |
Mean duration of disease (years) | 5.8 |
Mean Endoscopy Subscore | 2.4 |
UC location: n (%) | |
 Left-sided colitis | 5 (100) |
Mean modified Mayo Score (mMS) | 7.8 |
Anti-TNF antibodies: n (%) | |
 Infliximab (IFX) | 3 (60) |
 Adalimumab (ADA) | 2 (40) |
Refractory to prior anti-TNF antibody: n (%) | 5 (100) |
Concomitant anti-TNF antibody: n (%) | 5 (100) |
Concomitant corticosteroid: n (%) | 3 (60.0) |
Concomitant thiopurine: n (%) | 3 (60.0) |
Concomitant tacrolimus: n (%) | 2 (40.0) |
Concomitant 5-ASA: n (%) | 5 (100) |